Involvement of dendritic cells in the pathogenesis of inflammatory bowel disease

Advances in Experimental Medicine and Biology

Volumn 579, Issue , 2006, Pages 117-132

  Leon, Francisco ^a   Smythies, Lesley E ^b   Smith, Phillip D ^b   Kelsall, Brian L ^c  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b University of Alabama at Birmingham   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; DENDRITIC CELLS; HUMANS; INFLAMMATORY BOWEL DISEASES;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 34447617459     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/0-387-33778-4_8     Document Type: Review

References (133)

1. Kaisho T, Akira S. Regulation of dendritic cell function through toll-like receptors. Curr Mol Med 2003; 3(8):759-71.
2. Honda K, Sakaguchi S, Nakajima C et al. Selective contribution of IFN-cx/p signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection. Proc Natl Acad Sci USA 2003; 100(19):10872-7.
3. Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003; 425(6957):516-21.
4. Banchereau J, Briere F, Caux C et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18:767-811.
5. Kapsenberg ML. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 2003; 3(12):984-93.
6. Reis e Sousa C, Diebold SD, Edwards AD et al. Regulation of dendritic cell function by microbial stimuli. Pathol Biol (Paris) 2003; 51(2):67-8.
7. Rescigno M. Dendritic cells and the complexity of microbial infection. Trends Microbiol 2002; 10(9):425-61.
8. Wilson NS, El-Sukkari D, Villadangos JA. Dendritic cells constitutively present self antigens in their immature state in vivo, and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosis. Blood 2003.
9. Larsson M, Fonteneau JF, Bhardwaj N. Cross-presentation of cell-associated antigens by dendritic cells. Curr Top Microbiol Immunol 2003; 276:261-75.
10. Belz GT, Carbone FR, Heath WR. Cross-presentation of antigens by dendritic cells. Crit Rev Immunol 2002; 22(5-6):439-48.
11. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003; 21:685-711.
12. Ardavin C. Origin, precursors and differentiation of mouse dendritic cells. Nat Rev Immunol 2003; 3(7):582-90.
13. Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002; 2(3):151-61.
14. Wakkach A, Fournier N, Brun V et al. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 2003; 18(5):605-17.
15. Iwasaki A, Kelsall BL. Unique functions of CD11b+, CD8 alpha+, and double-negative Peyer's patch dendritic cells. J Immunol 2001; 166(8):4884-90.
16. Iwasaki A, Kelsall BL. Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3alpha, MIP-3beta, and secondary lymphoid organ chemokine. J Exp Med 2000; 191(8):1381-94.
17. Nakano H, Yanagita M, Gunn MD. CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J Exp Med 2001; 194(8):1171-8.
18. Asselin-Paturel C, Brizard G, Pin JJ et al. Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody. J Immunol 2003; 171(12):6466-77.
19. Asselin-Paturel C, Boonstra A, Dalod M et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol 2001; 2(12):1144-50.
20. O'Keeffe M, Hochrein H, Vremec D et al. Mouse plasmacytoid cells: Long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8(+) dendritic cells only after microbial stimulus. J Exp Med 2002; 196(10):1307-19.
21. Martin P, Del Hoyo GM, Anjuere F et al. Characterization of a new subpopulation of mouse CD8alpha+ B220+ dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential. Blood 2002; 100(2):383-90.
22. Bilsborough J, George TC, Norment A et al. Mucosal CD8alpha+ DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties. Immunology 2003; 108(4):481-92.
23. Maldonado-Lopez R, De Smedt T, Michel P et al. CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distina T helper cells in vivo. J Exp Med 1999; 189(3):587-92.
24. Pulendran B, Smith JL, Caspary G et al. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci USA 1999; 96(3):1036-41.
25. Maldonado-Lopez R, Maliszewski C, Urbain J et al. Cytokines regulate the capacity of CD8alpha(+) and CD8alpha(-) dendritic cells to prime Th1/Th2 cells in vivo. J Immunol 2001; l67(8):4345-50.
26. Iyoda T, Shimoyama S, Liu K et al. The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exp Med 2002; 195(10):1289-302.
27. Liu K, Iyoda T, Saternus M et al. Immune tolerance after delivery of dying cells to dendritic cells in situ. J Exp Med 2002; 196(8):1091-7.
28. den Haan JM, Lehar SM, Bevan MJ. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med 2000; 192(12):1685-96.
29. Belz GT, Behrens GM, Smith CM et al. The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J Exp Med 2002; 196(8):1099-104.
30. Boonstra A, Asselin-Paturel C, Gilliet M et al. Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: Dependency on antigen dose and differential toll-like receptor ligation. J Exp Med 2003; 197(1):101-9.
31. Mazzoni A, Segal DM. Controlling the toll road to dendritic cell polarization. J Leukoc Biol 2004.
32. McGuirk P, McCann C, Mills KH. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: A novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J Exp Med 2002; 195(2):221-31.
33. Mayrhofer G, Pugh CW, Barclay AN. The distribution, ontogeny and origin in the rat of Ia-positive cells with dendritic morphology and of Ia antigen in epithelia, with special reference to the intestine. Eur J Immunol 1983; 13(2):112-22.
34. Bland PW, Whiting CV. Differential control of major histocompatibility complex class II I-Ek alpha protein expression in the epithelium and in subsets of lamina propria antigen-presenting cells of the gut. Immunology 1993; 79(1):107-11.
35. Sminia T, Janse EM, Wilders MM. Antigen-trapping cells in Peyer's patches of the rat. Scand J Immunol 1982; l6(6):481-5.
36. Wilders MM, Sminia T, Plesch BE et al. Large mononuclear Ia-positive veiled cells in Peyer's patches. II. Localization in rat Peyer's patches. Immunology 1983; 48(3):461-7.
37. Wilders MM, Drexhage HA, Sminia T et al. Veiled cells in the gastrointestinal tract. Acta Chir Scand Suppl 1985; 525:93-111.
38. Soesatyo M, Biewenga J, Kraal G et al. The localization of macrophage subsets and dendritic cells in the gastrointestinal tract of the mouse with special reference to the presence of high endothelial venules. An immuno- and enzyme-histochemical study. Cell Tissue Res 1990; 259(3):587-93.
39. Sminia T, van der Ende MB. Macrophage subsets in the rat gut: An immunohistochemical and enzyme-histochemical study. Acta Histochem 1991; 90(l):43-50.
40. Soesatyo M, van den Berg TK, van Rees EP et al. Ontogeny of reticulum cells in the rat intestine and their possible role in the development of the lymphoid microenvironment. Reg Immunol 1992; 4(1):46-52.
41. Mahida YR, Patel S, Jewell DP. Mononuclear phagocyte system of human Peyer's patches: An immunohistochemical study using monoclonal antibodies. Clin Exp Immunol 1989; 75(1):82-6.
42. Nagura H, Ohtani H, Masuda T et al. HLA-DR expression on M cells overlying Peyer's patches is a common feature of human small intestine. Acta Pathol Jpn 1991; 41(11):818-23.
43. Pavli P, Woodhams CE, Doe WF et al. Isolation and characterization of antigen-presenting dendritic cells from the mouse intestinal lamina propria. Immunology 1990; 70(1):40-7.
44. Brandtzaeg P, Bjerke K. Immunomorphological characteristics of human Peyer's patches. Digestion 1990; 46 (Suppl 2):262-73.
45. Bjerke K, Halstensen TS, Jahnsen F et al. Distribution of macrophages and granulocytes expressing L1 protein (calprotectin) in human Peyer's patches compared with normal ileal lamina propria and mesenteric lymph nodes. Gut 1993; 34(10):1357-63.
46. Pavli P, Hume DA, Van De Pol E et al. Dendritic cells, the major antigen-presenting cells of the human colonic lamina propria. Immunology 1993; 78(1):132-41.
47. Marie I, Holt PC, Perdue MH et al. Class II MHC antigen (Ia)-bearing dendritic cells in the epithelium of the rat intestine. J Immunol 1996; 156(4):1408-14.
48. Liu LM, MacPherson GG. Rat intestinal dendritic cells: Immunostimulatory potency and phenotypic characterization. Immunology 1995; 85(1):88-93.
49. Pugh CW, MacPherson GG, Steer HW. Characterization of nonlymphoid cells derived from rat peripheral lymph. J Exp Med 1983; 157(6):1758-79.
50. MacPherson GG. Properties of lymph-borne (veiled) dendritic cells in culture. I. Modulation of phenotype, survival and ftinction: Partial dependence on GM-CSF. Immunology 1989; 68(1):102-7.
51. MacPherson GG, Jenkins CD, Stein MJ et al. Endotoxin-mediated dendritic cell release from the intestine. Characterization of released dendritic cells and TNF dependence. J Immunol 1995; 154(3):1317-22.
52. Liu LM, MacPherson GG. Lymph-borne (veiled) dendritic cells can acquire and present intestinally administered antigens. Immunology 1991; 73(3):281-6.
53. Liu LM, MacPherson GG. Antigen acquisition by dendritic cells: Intestinal dendritic cells acquire antigen administered orally and can prime naive T cells in vivo. J Exp Med 1993; 177(5):1299-307.
54. Spalding DM, Koopman WJ, Eldridge JH et al. Accessory cells in murine Peyer's patch. I Identification and enrichment of a functional dendritic cell. J Exp Med 1983; 157(5):1646-59.
55. Spencer J, Finn T, Isaacson PG. Human Peyer's patches: An immunohistochemical study. Gut 1986; 27(4):405-10.
56. Spalding DM, Williamson SI, Koopman WJ et al. Preferential induction of polyclonal IgA secretion by murine Peyer's patch dendritic cell-T cell mixtures. J Exp Med 1984; 160(3):941-6.
57. George A, Cebra JJ. Responses of single germinal-center B cells in T-cell-dependent microculture. Proc Natl Acad Sci USA 1991; 88(1):11-5.
58. Witmer MD, Steinman RM. The anatomy of peripheral lymphoid organs with emphasis on accessory cells: Light-microscopic immunocytochemical studies of mouse spleen, lymph node, and Peyer's patch. Am J Anat 1984; 170(3):465-81.
59. Witmer-Pack MD, Hughes DA, Schuler G et al. Identification of macrophages and dendritic cells in the osteopetrotic (op/op) mouse. J Cell Sci 1993; 104 (Pt 4):1021-9.
60. Kelsall BL, Strober W. Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyer's patch. J Exp Med 1996; 183(l):237-47.
61. Ruedl C, Hubele S. Maturation of Peyer's patch dendritic cells in vitro upon stimulation via cytokines or CD40 triggering. Eur J Immunol 1997; 27(6):1325-30.
62. Ruedl C, Rieser C, Bock G et al. Phenotypic and functional characterization of CD11c+ dendritic cell population in mouse Peyer's patches. Eur J Immunol 1996; 26(8):1801-6.
63. Hamada H, Hiroi T, Nishiyama Y et al. Identification of multiple isolated lymphoid follicles on the antimesenteric wall of the mouse small intestine. J Immunol 2002; 168:57-64.
64. Mora JR, Bono MR, Manjunath N et al. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 2003; 424(6944):88-93.
65. Iwasaki A, Kelsall BL. Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J Exp Med 1999; 190(2):229-39.
66. Everson MP, Lemak DC, McDuffie DS et al. Dendritic cells from Peyer's patch and spleen induce different T helper cell responses. J Interferon Cytokine Res 1998; 18(2):103-15.
67. Everson MP, McDuffie DS, Lemak DG et al. Dendritic cells from different tissues induce production of different T cell cytokine profiles. J Leukoc Biol 1996; 59(4):494-8.
68. Williamson E, Bilsborough JM, Viney JL. Regulation of mucosal dendritic cell fiinction by receptor activator of NF-kappa B (RANK)/RANK ligand interactions: Impact on tolerance induction. J Immunol 2002; 169(7):3606-12.
69. Jameson B, Baribaud F, Pohlmann S et al. Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques. J Virol 2002; 76(4):1866-75.
70. de Baey A, Mende I, Baretton G et al. A subset of human dendritic cells in the T cell area of mucosa-associated lymphoid tissue with a high potential to produce TNF-alpha. J Immunol 2003; 170(10):5089-94.
71. Huang FP, Piatt N, Wykes M et al. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med 2000; 191(3):435-44.
72. Alpan O, Rudomen G, Matzinger P. The role of dendritic cells, B cells, and M cells in gut-oriented immune responses. J Immunol 2001; 166(8):4843-52.
73. Akbari O, DeKruyff RH, Umetsu DT. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001; 2(8):725-31.
74. Stagg AJ, Kamm MA, Knight SC. Intestinal dendritic cells increase T cell expression of alpha4beta7 integrin. Eur J Immunol 2002; 32(5):1445-54.
75. Johansson-Lindbom B, Svensson M, Wurbel MA et al. Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): Requirement for GALT dendritic cells and adjuvant. J Exp Med 2003; 198(6):963-9.
76. Rescigno M, Urbano M, Valzasina B et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001; 2(4):361-7.
77. Mowat AM. Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 2003; 3(4):331-41.
78. Becker C, Wirtz S, Blessing M et al. Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. J Clin Invest 2003; 112(5):693-706.
79. Moghaddami M, Cummins A, Mayrhofer G. Lymphocyte-filled villi: Comparison with other lymphoid aggregations in the mucosa of the human small intestine. Gastroenterology 1998; 115(6):1414-25.
80. Bell SJ, Rigby R, English N et al. Migration and maturation of human colonic dendritic cells. J Immunol 2001; 166(8):4958-67.
81. te Velde AA, van Kooyk Y, Braat H et al. Increased expression of DC-SIGN+IL-12+IL-18+ and CD83+IL-12-IL-18- dendritic cell populations in the colonic mucosa of patients with Crohn's disease. Eur J Immunol 2003; 33(1):143-51.
82. Zhao X, Sato A, Dela Cruz CS et al. CCL9 is secreted by the follicle-associated epithelium and recruits dome region Peyer's patch CD11b+ dendritic cells. J Immunol 2003; 171(6):2797-803.
83. Caux C, Vanbervliet B, Massacrier C et al. Regulation of dendritic cell recruitment by chemokines. Transplantation 2002; 73(1 Suppl):S7-11.
84. Kunkel EJ, Campbell DJ, Butcher EC. Chemokines in lymphocyte trafficking and intestinal immunity. Microcirculation 2003; 10(3-4):313-23.
85. Papadakis KA. Chemokines in inflammatory bowel disease. Curr Allergy Asthma Rep 2004; 4(1):83-9.
86. Ajuebor MN, Swain MG. Role of chemokines and chemokine receptors in the gastrointestinal tract. Immunology 2002; 105(2):137-43.
87. Izadpanah A, Dwinell MB, Eckmann L et al. Regulated MIP-3alpha/CCL20 production by human intestinal epithelium: Mechanism for modulating mucosal immunity. Am J Physiol Gastrointest Liver Physiol 2001; 280(4):G710-9.
88. Dieu MC, Vanbervliet B, Vicari A et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 1998; 188(2):373-86.
89. Sakaguchi S, Fukuma K, Kuribayashi K et al. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I evidence for the active participation of T cells in natural self-tolerance; Deficit of a T cell subset as a possible cause of autoimmune disease. J Exp Med 1985; 161(1):72-87.
90. Wu HY, Weiner HL. Oral tolerance. Immunol Res 2003; 28(3):265-84.
91. Weiner HL. Oral tolerance: Immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. Microbes Infect 2001; 3(11):947-54.
92. Didierlaurent A, Sirard JC, Kraehenbuhl JP et al. How the gut senses its content. Cell Microbiol 2002; 4(2):61-72.
93. Barton CM, Medzhitov R. Toll-like receptors and their ligands. Curr Top Microbiol Immunol 2002; 270:81-92.
94. Gewirtz AT. Intestinal epithelial toll-like receptors: To protect. And serve? Curr Pharm Des 2003; 9(1):1-5.
95. Kagnoff MF, Eckmann L. Epithelial cells as sensors for microbial infection. J Clin Invest 1997; 100(1):6-10.
96. Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu Rev Immunol 2002; 20:495-549.
97. Uhlig HH, Powrie F. Dendritic cells and the intestinal bacterial flora: A role for localized mucosal immune responses. J Clin Invest 2003; 112(5):648-51.
98. Malmstrom V, Shipton D, Singh B et al. CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID mice. J Immunol 2001; 166(11):6972-81.
99. Mottet C, Uhlig HH, Powrie F. Cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 2003; 170:3939-43.
100. Yamazaki S, lyoda T, Tarbell K et al. Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J Exp Med 2003; 198:235-47.
101. Leithauser F, Trobonjaca Z, Moller P et al. Clustering of colonic lamina propria CD4(+) T cells to subepithelial dendritic cell aggregates precedes the development of colitis in a murine adoptive transfer model. Lab Invest 2001; 81(10):1339-49.
102. Krajina T, Leithauser F, Moller P et al. Colonic lamina propria dendritic cells in mice with CD4+ T cell-induced colitis. Eur J Immunol 2003; 33(4):1073-83.
103. Ashcrofi; AJ, Cruickshank SM, Croucher PI et al. Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin. Immunity 2003; 19:849-61.
104. Seldenrijk CA, Drexhage HA, Meuwissen SG et al. Dendritic cells and scavenger macrophages in chronic inflammatory bowel disease. Gut 1989; 30(4):486-91.
105. Oshitani N, Sawa Y, Hara J et al. Functional and phenotypical activation of leucocytes in inflamed human colonic mucosa. J Gastroenterol Hepatol 1997; 12(12):809-14.
106. Waraich T, Sarsfield P, Wright DH. The accessory cell populations in ulcerative colitis: A comparison between the colon and appendix in colitis and acute appendicitis. Hum Pathol 1997; 28(3):297-303.
107. Oshitani N, Kitano A, Kakazu T et al. Functional diversity of infiltrating macrophages in inflamed human colonic mucosa ulcerative colitis. Clin Exp Pharmacol Physiol 1998; 25(1):50-3.
108. MacDonald TT. The mucosal immune system. Parasite Immunol 2003; 25(5):235-46.
109. Stagg AJ, Hart AL, Knight SC et al. The dendritic cell: Its role in intestinal inflammation and relationship with gut bacteria. Gut 2003; 52(10):1522-9.
110. Kaser A, Ludwiczek O, Holzmann S et al. Increased expression of CCL20 in human inflammatory bowel disease. J Clin Immunol 2004; (24):74-85.
111. Vuckovic S, Florin TH, Khalil D et al. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases. Am J Gastroenterol 2001; 96(10):2946-56.
112. de Baey A, Mende I, Riethmueller G et al. Phenotype and function of human dendritic cells derived fi-om M-DC8(+) monocytes. Eur J Immunol 2001; 31(6):1646-55.
113. Murakami H, Akbar SM, Matsui H et al. Macrophage migration inhibitory factor activates antigen-presenting dendritic cells and induces inflammatory cytokines in ulcerative colitis. Clin Exp Immunol 2002; 128(3):504-10.
114. Yeung MM, Melgar S, Baranov V et al. Characterisation of mucosal lymphoid aggregates in ulcerative colitis: Immune cell phenotype and TcR-gammadelta expression. Gut 2000; 47:215-27.
115. Ikeda Y, Akbar F, Matsui H et al. Characterization of antigen-presenting dendritic cells in the peripheral blood and colonic mucosa of patients with ulcerative colitis. Eur J Gastroenterol Hepatol 2001; 13(7):841-50.
116. Christ AD, Stevens AC, Koeppen H et al. An interleukin 12-related cytokine is up-regulated in ulcerative colitis but not in Crohn's disease. Gastroenterology 1998; 115:307-13.
117. Nieuwenhuis EE, Neurath MF, Corazza N et al. Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice. Proc Natl Acad Sci USA 2002; 99:16951-6.
118. Heller F, Fuss IJ, Nieuwenhuis EE et al. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 2002; 17:629-38.
119. Fuss IJ, Heller F, Boirivant M et al. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest 2004; 113:1490-7.
120. Smith PD, Janoff EN, Mosteller-Barnum M et al. Isolation and purification of CD14-negative mucosal macrophages from normal human small intestine. J Immunoll Methods 1997; 202(1):1-11.
121. Smith PD, Smythies LE, Mosteller-Barnum M et al. Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J Immunol 2001; 167(5):2651-2656.
122. Smythies LE, Sellers M, Clements RH et al. Human intestinal macrophages display profound inflammatory energy despite avid phagocytic and bacteriocidal activity. J Clin Invest 2005; In Press.
123. + population of monocytes in inflammatory bowel disease mucosa implications for pathogenesis. Clin Expl Immunol 1995; 100(2):291-297.
124. Rogler G, Hausmann M, Vogl D et al. Isolation and phenotypic characterization of colonic macrophages. Clin Exp Immunol 1998; 112(2):205-215.
125. Hausmann M, Kiessling S, Mestermann S et al. Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 2002; 122(7):1987-2000.
126. Allison MC, Poulter LW. Changes in phenotypically distinct mucosal macrophage populations may be a prerequisite for the development of inflammatory bowel disease. Clin Exp Immunol 1991; 85(3):504-509.
127. Burgio VT, Fais S, Boirivant M et al. Peripheral monocyte and naive T-cell recruitment and activation in Crohn's disease. Gastroenterology 1995; 109(4):1029-1038.
128. Mahida YR, Patel S, Gionchetti P et al. Macrophage subpopulations in lamina propria of normal and inflamed colon and terminal ileum. Gut 1989; 30(6):826-834.
129. Rugtveit J, Brandtzaeg P, Halstensen TS et al. Increased macrophage subset in inflammatory bowel disease: Apparent recruitment from peripheral blood monocytes. Gut 1994; 35(5):669-674.
130. Grimm MC, Pullman WE, Benner GM et al. Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa. J Gastroenterol Hepatol 1995; 10(4):387-395.
131. Grip O, Janciauskiene S, Lindgren S. Macrophages in inflammatory bowel disease. Curr Drug Targets Inflamm Allergy 2003; 2(2):155-60.
132. Lochner M, Forster I. Anti-interleukin-18 therapy in murine models of inflammatory bowel disease. Pathobiology 2002-2003; 70:164-9.
133. Kanai T, Uraushihara K, Totsuka T et al. Macrophage-derived IL-18 targeting for the treatment of Crohn's disease. Curr Drug Targets Inflamm Allergy 2003; 2:131-6.